(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -17.39%2.47B | -22.58%1.55B | -4.66%790.09M | 3.71%4.02B | 4.86%2.99B | -1.33%2.01B | -14.00%828.72M | -3.41%3.88B | 7.80%2.85B | 22.78%2.03B |
Operating income | -17.39%2.47B | -22.58%1.55B | -4.66%790.09M | 3.71%4.02B | 4.86%2.99B | -1.33%2.01B | -14.00%828.72M | -3.41%3.88B | 7.80%2.85B | 22.78%2.03B |
Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.89%-1.62B |
Operating expenses | 18.29%-2.31B | 21.96%-1.48B | -0.47%-791.16M | -17.75%-3.85B | -19.34%-2.83B | -16.57%-1.89B | -3.32%-787.47M | -12.24%-3.27B | -25.25%-2.37B | -39.89%-1.62B |
Gross profit | -1.50%157.88M | -32.80%77.72M | -102.61%-1.08M | -71.47%174.15M | -66.61%160.29M | -71.89%115.67M | -79.53%41.24M | -44.69%610.38M | -36.11%480.02M | -17.16%411.43M |
Selling expenses | 2.69%-59.76M | -16.46%-38.31M | 3.09%-16.05M | 20.39%-90.59M | 19.61%-61.41M | 31.77%-32.89M | 29.93%-16.56M | -4.04%-113.8M | 12.20%-76.39M | 16.53%-48.21M |
Administrative expenses | 5.76%-286.08M | 1.91%-187.31M | 9.18%-89.17M | 0.49%-436.8M | 0.86%-303.58M | -0.53%-190.97M | -5.51%-98.19M | -7.69%-438.93M | -5.21%-306.2M | -4.16%-189.96M |
Research and development expenses | 12.25%-101.11M | -2.05%-65.04M | -8.78%-32.08M | -5.12%-171.16M | -0.52%-115.23M | ---63.74M | 29.62%-29.49M | ---162.83M | -15.11%-114.64M | ---- |
Profit from asset sales | -224.45%-625.35K | -93.67%29.66K | 1,616.33%93.87K | -26.52%710.82K | 11.75%502.49K | --468.89K | -15,577.13%-6.19K | --967.39K | -88.08%449.65K | ---- |
Revaluation surplus | 523.97%4.63M | --2.88M | --1.72M | 90.83%-440.33K | --742.05K | ---- | ---- | ---4.8M | ---- | ---- |
-Changes in the fair value of other assets | 523.97%4.63M | --2.88M | --1.72M | 90.83%-440.33K | --742.05K | ---- | ---- | ---4.8M | ---- | ---- |
Impairment and provision | 56.59%-4.13M | 7.36%-3.64M | -311.90%-1.52M | 33.80%-198.06M | 33.98%-9.51M | 73.54%-3.93M | -21.47%719.35K | -164.55%-299.18M | -26.84%-14.41M | -192.82%-14.86M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.63M |
-Other impairment is provision | 56.59%-4.13M | 7.36%-3.64M | -311.90%-1.52M | 33.80%-198.06M | 33.98%-9.51M | 36.90%-3.93M | -21.47%719.35K | -421.37%-299.18M | -26.84%-14.41M | -22.77%-6.23M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.22%-84.22M |
Special items of operating profit | 4.65%33.92M | -20.19%15.73M | -44.29%3.82M | -21.61%50.79M | -38.39%32.41M | 136.20%19.71M | -46.28%6.86M | 140.35%64.8M | -9.46%52.61M | 16.12%-54.44M |
Operating profit | 13.29%-285.71M | -23.20%-219.9M | -36.73%-144.18M | -83.28%-718.35M | -3,063.36%-329.52M | -1,003.81%-178.49M | -326.32%-105.44M | -320.29%-391.94M | -103.54%-10.42M | -84.54%19.75M |
Financing cost | -19.61%-142.36M | -17.99%-93.9M | -15.12%-46.99M | -2.70%-168.97M | 0.51%-119.02M | ---79.58M | 4.75%-40.81M | ---164.53M | -36.58%-119.62M | ---- |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -422.82%-2.22M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.64%45K |
Special items of earning before tax | -106.59%-52.15K | -219.92%-1.25M | 141.42%84.5K | -99.23%124.22K | -93.54%790.84K | --1.04M | -295.81%-204.01K | --16.2M | 252.53%12.24M | ---- |
Earning before tax | 4.38%-428.12M | -22.57%-315.04M | -30.46%-191.08M | -64.21%-887.19M | -280.08%-447.75M | -1,562.72%-257.03M | -3,906.96%-146.46M | -382.12%-540.27M | -159.33%-117.8M | -87.44%17.57M |
Tax | -578.69%-7.13M | -245.22%-4.27M | -60.17%-1.86M | 91.06%-2.28M | 112.45%1.49M | 127.11%2.94M | 81.80%-1.16M | 28.58%-25.47M | 55.33%-11.97M | 44.39%-10.86M |
After-tax profit from continuing operations | 2.47%-435.25M | -25.67%-319.31M | -30.70%-192.94M | -57.22%-889.47M | -243.89%-446.26M | -3,883.86%-254.09M | -5,691.39%-147.62M | -463.02%-565.74M | -175.55%-129.77M | -94.42%6.72M |
Earning after tax | 2.47%-435.25M | -25.67%-319.31M | -30.70%-192.94M | -57.22%-889.47M | -243.89%-446.26M | -3,883.86%-254.09M | -5,691.39%-147.62M | -463.02%-565.74M | -175.55%-129.77M | -94.42%6.72M |
Minority profit | 9.37%-80.97M | -12.31%-61.96M | -23.73%-37.07M | -108.49%-139M | -126.04%-89.34M | -302.81%-55.17M | -284.76%-29.97M | -1,259.79%-66.67M | -522.29%-39.52M | -256.42%-13.7M |
Profit attributable to shareholders | 0.74%-354.28M | -29.38%-257.36M | -32.47%-155.87M | -50.37%-750.47M | -295.50%-356.92M | -1,074.62%-198.92M | -2,345.86%-117.66M | -410.47%-499.07M | -155.57%-90.25M | -81.71%20.41M |
Basic earnings per share | 0.00%-0.32 | -15.00%-0.23 | -7.69%-0.14 | -30.76%-0.7422 | -220.00%-0.32 | -962.07%-0.2 | -1,400.00%-0.13 | -415.33%-0.5676 | -155.56%-0.1 | -81.72%0.0232 |
Diluted earnings per share | 0.00%-0.32 | -15.00%-0.23 | -7.69%-0.14 | -30.76%-0.7422 | -220.00%-0.32 | -962.07%-0.2 | -1,400.00%-0.13 | -415.33%-0.5676 | -155.56%-0.1 | -81.72%0.0232 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited, CCA Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data